PROTEOMICS INT LAB ORDINARY (PIQ) Short Interest
PROTEOMICS INT LAB ORDINARY (ASX:PIQ) had 0.53% of shares reported as short positions as of 16 May 2026, representing 871,240 shares. PROTEOMICS INT LAB ORDINARY operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).
- Short interest
- 0.53%
- Reported positions
- 871,240
- Industry
- Pharmaceuticals, Biotechnology & Life Sciences
- As of
- 16 May 2026
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
PIQ
Proteomics International Laboratories
Proteomics International Laboratories Ltd (ASX:PIQ) is a medical technology company specializing in predictive diagnostics and bio-analytical services. They focus on proteomics, the industrial-scale study of protein structure and function, to develop novel diagnostic tests like PromarkerD, PromarkerEndo, and PromarkerEso, aiming to bring these to global markets.